Tags

Type your tag names separated by a space and hit enter

Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity?
Obes Surg. 2006 Feb; 16(2):166-71.OS

Abstract

BACKGROUND

Sleeve gastrectomy as the sole bariatric operation has been reported for high-risk super-obese patients or as first-step followed by Roux-en-Y gastric bypass (RYGBP) or duodenal switch (DS) in super-super obese patients. The efficacy of laparoscopic sleeve gastrectomy (LSG) for morbidly obese patients with a BMI of <50 kg/m2 and the incidence of gastric dilatation following LSG have not yet been investigated.

METHODS

23 patients (15 morbidly obese, 8 super-obese) were studied prospectively for weight loss following LSG. The incidence of sleeve dilatation was assessed by upper GI contrast studies in patients with a follow-up of >12 months.

RESULTS

Patients who underwent LSG achieved a mean excess weight loss (EWL) at 6 and 12 months postoperatively of 46% and 56%, respectively. No significant differences were observed in %EWL comparing obese and super-obese patients. At a mean follow-up of 20 months, dilatation of the gastric sleeve was found in 1 patient and weight regain after initial successful weight loss in 3 of the 23 patients.

CONCLUSION

LSG has been highly effective for weight reduction for morbid obesity even as the sole bariatric operation. Gastric dilatation was found in only 1 patient in this short-term follow-up. Weight regain following LSG may require conversion to RYGBP or DS. Follow-up will be necessary to evaluate long-term results.

Authors+Show Affiliations

Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16469218

Citation

Langer, Felix B., et al. "Does Gastric Dilatation Limit the Success of Sleeve Gastrectomy as a Sole Operation for Morbid Obesity?" Obesity Surgery, vol. 16, no. 2, 2006, pp. 166-71.
Langer FB, Bohdjalian A, Felberbauer FX, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16(2):166-71.
Langer, F. B., Bohdjalian, A., Felberbauer, F. X., Fleischmann, E., Reza Hoda, M. A., Ludvik, B., Zacherl, J., Jakesz, R., & Prager, G. (2006). Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obesity Surgery, 16(2), 166-71.
Langer FB, et al. Does Gastric Dilatation Limit the Success of Sleeve Gastrectomy as a Sole Operation for Morbid Obesity. Obes Surg. 2006;16(2):166-71. PubMed PMID: 16469218.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? AU - Langer,Felix B, AU - Bohdjalian,Arthur, AU - Felberbauer,Franz X, AU - Fleischmann,Edith, AU - Reza Hoda,Mir A, AU - Ludvik,Bernhard, AU - Zacherl,Johannes, AU - Jakesz,Raimund, AU - Prager,Gerhard, PY - 2006/2/14/pubmed PY - 2006/6/10/medline PY - 2006/2/14/entrez SP - 166 EP - 71 JF - Obesity surgery JO - Obes Surg VL - 16 IS - 2 N2 - BACKGROUND: Sleeve gastrectomy as the sole bariatric operation has been reported for high-risk super-obese patients or as first-step followed by Roux-en-Y gastric bypass (RYGBP) or duodenal switch (DS) in super-super obese patients. The efficacy of laparoscopic sleeve gastrectomy (LSG) for morbidly obese patients with a BMI of <50 kg/m2 and the incidence of gastric dilatation following LSG have not yet been investigated. METHODS: 23 patients (15 morbidly obese, 8 super-obese) were studied prospectively for weight loss following LSG. The incidence of sleeve dilatation was assessed by upper GI contrast studies in patients with a follow-up of >12 months. RESULTS: Patients who underwent LSG achieved a mean excess weight loss (EWL) at 6 and 12 months postoperatively of 46% and 56%, respectively. No significant differences were observed in %EWL comparing obese and super-obese patients. At a mean follow-up of 20 months, dilatation of the gastric sleeve was found in 1 patient and weight regain after initial successful weight loss in 3 of the 23 patients. CONCLUSION: LSG has been highly effective for weight reduction for morbid obesity even as the sole bariatric operation. Gastric dilatation was found in only 1 patient in this short-term follow-up. Weight regain following LSG may require conversion to RYGBP or DS. Follow-up will be necessary to evaluate long-term results. SN - 0960-8923 UR - https://www.unboundmedicine.com/medline/citation/16469218/Does_gastric_dilatation_limit_the_success_of_sleeve_gastrectomy_as_a_sole_operation_for_morbid_obesity L2 - https://dx.doi.org/10.1381/096089206775565276 DB - PRIME DP - Unbound Medicine ER -